4587.T
PeptiDream Inc.
プライム · 医薬品 · 医薬品 · JP
JPY 1,098.00
+2.09%Price chart
Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
12.0x
EV/EBITDA
−49.8x
Market Cap
JPY 141.98B
MomentumView details →
1D Return
+2.09%
YTD Return
−35.47%
RSI (14)
53.0
ValuationView details →
P/E (Fwd)
12.0x
EV/EBITDA
−49.8x
Market Cap
JPY 141.98B
RSI (14)
53.0
MomentumView details →
1D Return
+2.09%
YTD Return
−35.47%
Similar companies
Latest newsMore news →
PeptiDream announced on August 12 that it received a milestone payment from Novartis for the initiation of a Phase 1 clinical trial of a compound created through their joint research.24d agoPeptiDream announced its IFRS results for the first half of 2026 (January-June), with a consolidated net loss of 1.99 billion yen, narrowing from a loss of 2.12 billion yen in the same period last year.24d agoPeptiDream announced plans to launch its first proprietary drug by 2032, with a Phase 1 clinical trial for a kidney cancer radiopharmaceutical candidate started in July 2026.24d ago